A PYMNTS Company

Canada Reaches Agreement With Evonik Over PeroxyChem Buy

By  |  January 28, 2020

The Competition Bureau announced that it reached an agreement with Evonik Industries to address competition concerns related to its proposed acquisition of PeroxyChem.

Following an extensive review, the Bureau concluded that Evonik’s acquisition of PeroxyChem was likely to result in a substantial lessening of competition in the supply of hydrogen peroxide in Western Canada.

To remedy this concern, Evonik has agreed to sell PeroxyChem’s hydrogen peroxide manufacturing facility located in Prince George, British Columbia and related assets to a buyer acceptable to the Commissioner of Competition.

Under the agreement registered with the Competition Tribunal, Evonik has proposed United Initiators (UI) as the buyer of this facility. The Commissioner reviewed UI’s suitability and concluded that they are an acceptable buyer.

The Bureau is satisfied that this agreement will preserve competition in Western Canada’s hydrogen peroxide market.

Full Content: Canada

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.